Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses.

Anderson DJ, Rojas LF, Watson S, Knelson LP, Pruitt S, Lewis SS, Moehring RW, Sickbert Bennett EE, Weber DJ, Chen LF, Sexton DJ; CDC Prevention Epicenters Program.

PLoS One. 2017 May 16;12(5):e0176285. doi: 10.1371/journal.pone.0176285. eCollection 2017.

2.

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC prevention epicenters program.

Ann Clin Microbiol Antimicrob. 2017 Apr 8;16(1):25. doi: 10.1186/s12941-017-0202-4.

3.

Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles.

Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK; CDC Prevention Epicenters Program.

BMC Microbiol. 2017 Mar 31;17(1):78. doi: 10.1186/s12866-017-0983-9.

4.

Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Nachamkin I, Coffin SE, Davis MF, Julian KG, Zaoutis TE, Metlay JP, Linkin DR, Tolomeo P, Wise JA, Bilker WB, Hu B, Lautenbach E; CDC PREVENTION EPICENTERS PROGRAM.

Epidemiol Infect. 2017 May;145(7):1409-1417. doi: 10.1017/S0950268817000012. Epub 2017 Feb 21.

PMID:
28219463
5.

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.

Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, Blocker M, Becherer P, Schwab JC, Knelson LP, Lokhnygina Y, Rutala WA, Kanamori H, Gergen MF, Sexton DJ; CDC Prevention Epicenters Program.

Lancet. 2017 Feb 25;389(10071):805-814. doi: 10.1016/S0140-6736(16)31588-4. Epub 2017 Jan 17.

PMID:
28104287
6.

Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.

Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, Santana E, Tolomeo P, Maslow J, Myers J, Carson L, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Diagn Microbiol Infect Dis. 2017 Mar;87(3):275-280. doi: 10.1016/j.diagmicrobio.2016.11.016. Epub 2016 Nov 28.

PMID:
27939288
7.

An Evaluation of Antibiotic Prescribing Practices Upon Hospital Discharge.

Scarpato SJ, Timko DR, Cluzet VC, Dougherty JP, Nunez JJ, Fishman NO, Hamilton KW; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):353-355. doi: 10.1017/ice.2016.276. Epub 2016 Nov 28.

PMID:
27890038
8.

Using a Human Factors Engineering Approach to Improve Patient Room Cleaning and Disinfection.

Rock C, Cosgrove SE, Keller SC, Enos-Graves H, Andonian J, Maragakis LL, Gurses AP, Xie A; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1502-1506. Epub 2016 Sep 26. No abstract available.

PMID:
27666398
9.

Hand Hygiene Compliance in the Setting of Trauma Resuscitation.

Haac B, Rock C, Harris AD, Pineles L, Stein D, Scalea T, Hu P, Hagegeorge G, Liang SY, Thom KA; CDC Prevention Epicenters Program.

Injury. 2017 Jan;48(1):165-170. doi: 10.1016/j.injury.2016.08.004. Epub 2016 Aug 17.

PMID:
27568844
10.

Assessment of Self-Contamination During Removal of Personal Protective Equipment for Ebola Patient Care.

Casanova LM, Teal LJ, Sickbert-Bennett EE, Anderson DJ, Sexton DJ, Rutala WA, Weber DJ; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1156-61. doi: 10.1017/ice.2016.169. Epub 2016 Aug 1.

PMID:
27477451
11.

The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Metlay JP, Nachamkin I, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Wheeler MK, Hu B, Fishman NO, Royer D, Lautenbach E; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1226-33. doi: 10.1017/ice.2016.138. Epub 2016 Jul 28.

PMID:
27465112
12.

Associations Between Different Sedatives and Ventilator-Associated Events, Length of Stay, and Mortality in Patients Who Were Mechanically Ventilated.

Klompas M, Li L, Szumita P, Kleinman K, Murphy MV; CDC Prevention Epicenters Program.

Chest. 2016 Jun;149(6):1373-9. doi: 10.1378/chest.15-1389. Epub 2016 Jan 11.

PMID:
26501514
13.

Environmental transmission of Clostridium difficile: association between hospital room size and C. difficile Infection.

Jou J, Ebrahim J, Shofer FS, Hamilton KW, Stern J, Han JH; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2015 May;36(5):564-8. doi: 10.1017/ice.2015.18. Epub 2015 Feb 5.

14.

Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC Prevention Epicenters Program.

J Antimicrob Chemother. 2015 May;70(5):1547-51. doi: 10.1093/jac/dku548. Epub 2015 Jan 27.

15.

Catheter salvage in home infusion patients with central line-associated bloodstream infection.

Caroff DA, Norris AH, Keller S, Vinnard C, Zeitler KE, Lukaszewicz J, Zborowski KA, Linkin DR; CDC Prevention Epicenters Program.

Am J Infect Control. 2014 Dec;42(12):1331-3. doi: 10.1016/j.ajic.2014.08.015. Epub 2014 Nov 25.

16.

Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.

Han JH, Johnston B, Nachamkin I, Tolomeo P, Bilker WB, Mao X, Clabots C, Lautenbach E, Johnson JR; CDC Prevention Epicenters Program.

Antimicrob Agents Chemother. 2014 Nov;58(11):7003-6. doi: 10.1128/AAC.03256-14. Epub 2014 Sep 8.

17.

Medicare claims can be used to identify US hospitals with higher rates of surgical site infection following vascular surgery.

Calderwood MS, Kleinman K, Bratzler DW, Ma A, Kaganov RE, Bruce CB, Balaconis EC, Canning C, Platt R, Huang SS; CDC Prevention Epicenters Program; Oklahoma Foundation for Medical Quality.

Med Care. 2014 Oct;52(10):918-25. doi: 10.1097/MLR.0000000000000212.

PMID:
25185638
18.

The Bristol stool scale and its relationship to Clostridium difficile infection.

Caroff DA, Edelstein PH, Hamilton K, Pegues DA; CDC Prevention Epicenters Program.

J Clin Microbiol. 2014 Sep;52(9):3437-9. doi: 10.1128/JCM.01303-14. Epub 2014 Jul 16.

19.

Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Calderwood MS, Desjardins CA, Sakoulas G, Nicol R, Dubois A, Delaney ML, Kleinman K, Cosimi LA, Feldgarden M, Onderdonk AB, Birren BW, Platt R, Huang SS; CDC Prevention Epicenters Program.

J Infect Dis. 2014 Feb 15;209(4):571-7. doi: 10.1093/infdis/jit501. Epub 2013 Sep 16.

20.

Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.

Khair HN, VanTassell P, Henderson JP, Warren DK, Marschall J; CDC Prevention Epicenters Program.

J Hosp Infect. 2013 Nov;85(3):183-8. doi: 10.1016/j.jhin.2013.07.007. Epub 2013 Aug 30.

Supplemental Content

Loading ...
Support Center